Should the new pneumococcal vaccine be used in high-risk children?

被引:17
作者
Finn, A
Booy, R
Moxon, R
Sharland, M
Heath, P
机构
[1] UBHT, Inst Child Hlth, Educ Ctr, Bristol BS2 8AE, Avon, England
[2] Univ London St Georges Hosp, Sch Med, London SW17 0RE, England
[3] St Georges Vaccine Inst, London, England
[4] Oxford Vaccine Grp, Oxford, England
[5] Royal London Hosp, London E1 1BB, England
关键词
D O I
10.1136/adc.87.1.18
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A new conjugate 7-valent vaccine to prevent pneumococcal infection (Prevenar, Wyeth) has recently received a European licence for use in young healthy children. The vaccine is not currently included in the universal immunisation schedule in the UK or elsewhere in Europe, although it is being used widely in the USA. Its availability for purchase raises the question whether paediatricians should consider using it in high risk children, including those for whom the polysaccharide 23-valent vaccine was previously recommended, until (or unless) it is introduced into general use-indeed the Chief Medical Officer for England and Wales has recently made a recommendation regarding such children aged less than 2 years. We review the evidence concerning use of the vaccine in such children and make suggestions as to how the vaccine may be used while further information is collected.
引用
收藏
页码:18 / 21
页数:4
相关论文
共 37 条
[1]  
Abramson JS, 2000, PEDIATRICS, V106, P362
[2]   INVASIVE BACTERIAL-INFECTIONS IN CHILDREN BORN TO WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ANDIMAN, WA ;
MEZGER, J ;
SHAPIRO, E .
JOURNAL OF PEDIATRICS, 1994, 124 (06) :846-852
[3]   PREVENTION OF MENINGOCOCCAL DISEASE BY GROUP-C POLYSACCHARIDE VACCINE [J].
ARTENSTEIN, MS ;
GOLD, R ;
ZIMMERLY, JG ;
WYLE, FA ;
SCHNEIDER, H ;
HARKINS, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (08) :417-+
[4]   Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children [J].
Barnett, ED ;
Pelton, SI ;
Cabral, HJ ;
Eavey, RD ;
Allen, C ;
Cunningham, MJ ;
McNamara, ER ;
Klein, JO .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :191-192
[5]   BACTERIAL-INFECTION IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME OF CHILDREN [J].
BERNSTEIN, LJ ;
KRIEGER, BZ ;
NOVICK, B ;
SICKLICK, MJ ;
RUBINSTEIN, A .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (05) :472-475
[6]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[7]  
Cavill I, 1996, BRIT MED J, V312, P430
[8]  
*CHIEF MED OFF, 2002, PNEUM VACC RISK 2 YE
[9]   New pneumococcal vaccines for children [J].
Choo, S ;
Finn, A .
ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (04) :289-294
[10]   Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine in United Kingdom infants [J].
Choo, S ;
Seymour, L ;
Morris, R ;
Quataert, S ;
Lockhart, S ;
Cartwright, K ;
Finn, A .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (09) :854-862